Change history
22 June 2017
In the June 2017 issue, the story “Biased for benefit: Stimulating the world’s most popular drug targets with more nuance” (Nat. Med. 23, 649–651, 2017) misspelled the name of Laura Bohn’s postdoctoral advisor as Mark Caron. It should be spelled Marc Caron. The error has been corrected in the HTML and PDF versions of the article.
References
Boerrigter, G. et al. Circ. Heart Fail. 5, 627–634 (2012).
Benjamin, E.J. et al. Circ. 135, e146–e603 (2017).
Collins, S. et al. J. Cardiol. Fail. 21, 27–43 (2015).
Santos, R. et al. Nat. Rev. Drug Discov. 16, 19–34 (2017).
Rajagopal, K. et al. Proc. Nat. Acad. Sci. USA 103, 16284–16289 (2006).
Aplin, M. et al. Basic Clin. Pharmacol. Toxicol. 100, 289–295 (2007).
Kim, K.S. et al. Am. J. Physiol. Heart. Circ. Physiol. 303, H1001–H1010 (2012).
Luttrell, L.M. et al. Science 283, 655–661 (1999).
Pang, P.S. et al. Eur. Heart J. 10.1093/eurheartj/ehx196 (2017).
Pradhan, A.A. et al. Br. J. Pharmacol. 167, 960–969 (2012).
Nozaki, C. et al. J. Pharmacol. Exp. Ther. 342, 799–807 (2012).
Bohn, L.M. et al. Science 286, 2495–2498 (1999).
Raehal, K.M. et al. J. Pharmacol. Exp. Ther. 314, 1195–1201 (2005).
Rudd, R.A. et al. MMWR Morb. Mortal. Wkly Rep. 65, 1445–1452 (2016).
Manglik, A. et al. Nature 537, 185–190 (2016).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lewis, D. Biased for benefit: Stimulating the world's most popular drug targets with more nuance. Nat Med 23, 649–651 (2017). https://doi.org/10.1038/nm0617-649
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0617-649
- Springer Nature America, Inc.
This article is cited by
-
Correction
Nature Medicine (2017)